Dear ASHG Members, Today ASHG is releasing a new report on how human genetics and genomics is growing the U.S. economy and becoming increasingly integrated in healthcare and society. The new report, titled “The Economic Impact and Functional Applications of Human Genetics and Genomics,” indicates that the human genetics and genomics sector contributes $265 billion... Read More
Posted By: Lyly Luhachack, PhD, Policy & Advocacy Specialist, ASHG April 22, 2021, marked the first-ever ASHG Capitol Hill Day. The Government and Public Advocacy Committee (GPAC), ASHG President Gail Jarvik, MD, PhD, Dana Crawford, PhD, Diversity, Equity, and Inclusion Task Force (DEITF) Chair, and leaders of the Career Development Committee (CDC) met, virtually, with... Read More
Each year, Congress is tasked with setting budgets across the federal government, including for the National Institutes of Health (NIH), before October 1, the beginning of the new fiscal year. However, this month we passed the October 1 deadline without Congress passing legislation to accomplish this for Fiscal Year 2021. This means that the size... Read More
June 2020 ASHG is committed to supporting diversity and inclusion initiatives in genetics research and building a scientific community that is welcoming to all. Genetic studies have largely focused on populations of European descent, and more work is needed to create diverse reference datasets. These tools can help to aid precision medicine discoveries for all... Read More
Shortly after the first cases of the novel coronavirus were reported, human geneticists around the world began to collaborate on investigating the host genetic determinants of COVID-19 susceptibility. Led by Andrea Ganna, PhD, and Mark Daly, PhD, at the Institute of Molecular Medicine, Finland, the COVID-19 Host Genetics Initiative currently has about 160 registered studies... Read More